Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy

Andrea Barsevick, Susan L. Beck, William N. Dudley, Bob Wong, Ann Malone Berger, Kyra Whitmer, Tracey Newhall, Susan Brown, Katie Stewart

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Context: Multiple complex symptoms from cancer treatment can interfere with functioning. Objectives: To evaluate the efficacy of an "energy and sleep enhancement" (EASE) intervention to relieve fatigue and sleep disturbance and improve health-related functional status. Methods: Individuals receiving chemotherapy (CTX) were randomized to the EASE (n = 153) or a control intervention (n = 139). The EASE intervention included information and behavioral skills taught by an oncology nurse in three telephone sessions. The primary outcomes of fatigue, sleep disturbance, and functional status were measured before CTX, Day 4 after first treatment (baseline), and 43-46 or 57-60 days later (follow-up), depending on the CTX cycle length. Results: The sample was primarily female (82%) and non-Hispanic white (89%), with mean age of 53.9 years. Fatigue and patient-reported sleep disturbance were elevated in both groups at baseline and follow-up. Actigraphy revealed that the total sleep time was almost eight hours, and sleep percent was greater than 85% for both groups at both time points (normal range). Physical functioning was diminished and at the same level as a sample with serious illness. Mental functioning was in normal range. A repeated-measures analysis of variance revealed no statistically significant group-by-time effects for fatigue, sleep disturbance, or functional status. Unemployed individuals showed greater benefit from the EASE intervention, reporting less pain and symptom interference. Conclusion: Potential explanations include high variability and/or floor effect for fatigue, incorrect timing of measures, insufficient amount or dose of the intervention, and confounding effects of gender. Future research should consider screening for symptom severity and tailoring interventions.

Original languageEnglish (US)
Pages (from-to)200-216
Number of pages17
JournalJournal of Pain and Symptom Management
Volume40
Issue number2
DOIs
StatePublished - Aug 1 2010

Fingerprint

Fatigue
Sleep
Drug Therapy
Neoplasms
Reference Values
Actigraphy
Telephone
Analysis of Variance
Nurses
Pain
Health
Therapeutics

Keywords

  • Cancer-related fatigue
  • actigraphy
  • psychoeducational intervention
  • randomized controlled trial
  • sleep disturbance
  • symptom cluster
  • telephone counseling

ASJC Scopus subject areas

  • Nursing(all)
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. / Barsevick, Andrea; Beck, Susan L.; Dudley, William N.; Wong, Bob; Berger, Ann Malone; Whitmer, Kyra; Newhall, Tracey; Brown, Susan; Stewart, Katie.

In: Journal of Pain and Symptom Management, Vol. 40, No. 2, 01.08.2010, p. 200-216.

Research output: Contribution to journalArticle

Barsevick, A, Beck, SL, Dudley, WN, Wong, B, Berger, AM, Whitmer, K, Newhall, T, Brown, S & Stewart, K 2010, 'Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy', Journal of Pain and Symptom Management, vol. 40, no. 2, pp. 200-216. https://doi.org/10.1016/j.jpainsymman.2009.12.020
Barsevick, Andrea ; Beck, Susan L. ; Dudley, William N. ; Wong, Bob ; Berger, Ann Malone ; Whitmer, Kyra ; Newhall, Tracey ; Brown, Susan ; Stewart, Katie. / Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. In: Journal of Pain and Symptom Management. 2010 ; Vol. 40, No. 2. pp. 200-216.
@article{1ef43110e3144a709b0828955f1cea8a,
title = "Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy",
abstract = "Context: Multiple complex symptoms from cancer treatment can interfere with functioning. Objectives: To evaluate the efficacy of an {"}energy and sleep enhancement{"} (EASE) intervention to relieve fatigue and sleep disturbance and improve health-related functional status. Methods: Individuals receiving chemotherapy (CTX) were randomized to the EASE (n = 153) or a control intervention (n = 139). The EASE intervention included information and behavioral skills taught by an oncology nurse in three telephone sessions. The primary outcomes of fatigue, sleep disturbance, and functional status were measured before CTX, Day 4 after first treatment (baseline), and 43-46 or 57-60 days later (follow-up), depending on the CTX cycle length. Results: The sample was primarily female (82{\%}) and non-Hispanic white (89{\%}), with mean age of 53.9 years. Fatigue and patient-reported sleep disturbance were elevated in both groups at baseline and follow-up. Actigraphy revealed that the total sleep time was almost eight hours, and sleep percent was greater than 85{\%} for both groups at both time points (normal range). Physical functioning was diminished and at the same level as a sample with serious illness. Mental functioning was in normal range. A repeated-measures analysis of variance revealed no statistically significant group-by-time effects for fatigue, sleep disturbance, or functional status. Unemployed individuals showed greater benefit from the EASE intervention, reporting less pain and symptom interference. Conclusion: Potential explanations include high variability and/or floor effect for fatigue, incorrect timing of measures, insufficient amount or dose of the intervention, and confounding effects of gender. Future research should consider screening for symptom severity and tailoring interventions.",
keywords = "Cancer-related fatigue, actigraphy, psychoeducational intervention, randomized controlled trial, sleep disturbance, symptom cluster, telephone counseling",
author = "Andrea Barsevick and Beck, {Susan L.} and Dudley, {William N.} and Bob Wong and Berger, {Ann Malone} and Kyra Whitmer and Tracey Newhall and Susan Brown and Katie Stewart",
year = "2010",
month = "8",
day = "1",
doi = "10.1016/j.jpainsymman.2009.12.020",
language = "English (US)",
volume = "40",
pages = "200--216",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy

AU - Barsevick, Andrea

AU - Beck, Susan L.

AU - Dudley, William N.

AU - Wong, Bob

AU - Berger, Ann Malone

AU - Whitmer, Kyra

AU - Newhall, Tracey

AU - Brown, Susan

AU - Stewart, Katie

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Context: Multiple complex symptoms from cancer treatment can interfere with functioning. Objectives: To evaluate the efficacy of an "energy and sleep enhancement" (EASE) intervention to relieve fatigue and sleep disturbance and improve health-related functional status. Methods: Individuals receiving chemotherapy (CTX) were randomized to the EASE (n = 153) or a control intervention (n = 139). The EASE intervention included information and behavioral skills taught by an oncology nurse in three telephone sessions. The primary outcomes of fatigue, sleep disturbance, and functional status were measured before CTX, Day 4 after first treatment (baseline), and 43-46 or 57-60 days later (follow-up), depending on the CTX cycle length. Results: The sample was primarily female (82%) and non-Hispanic white (89%), with mean age of 53.9 years. Fatigue and patient-reported sleep disturbance were elevated in both groups at baseline and follow-up. Actigraphy revealed that the total sleep time was almost eight hours, and sleep percent was greater than 85% for both groups at both time points (normal range). Physical functioning was diminished and at the same level as a sample with serious illness. Mental functioning was in normal range. A repeated-measures analysis of variance revealed no statistically significant group-by-time effects for fatigue, sleep disturbance, or functional status. Unemployed individuals showed greater benefit from the EASE intervention, reporting less pain and symptom interference. Conclusion: Potential explanations include high variability and/or floor effect for fatigue, incorrect timing of measures, insufficient amount or dose of the intervention, and confounding effects of gender. Future research should consider screening for symptom severity and tailoring interventions.

AB - Context: Multiple complex symptoms from cancer treatment can interfere with functioning. Objectives: To evaluate the efficacy of an "energy and sleep enhancement" (EASE) intervention to relieve fatigue and sleep disturbance and improve health-related functional status. Methods: Individuals receiving chemotherapy (CTX) were randomized to the EASE (n = 153) or a control intervention (n = 139). The EASE intervention included information and behavioral skills taught by an oncology nurse in three telephone sessions. The primary outcomes of fatigue, sleep disturbance, and functional status were measured before CTX, Day 4 after first treatment (baseline), and 43-46 or 57-60 days later (follow-up), depending on the CTX cycle length. Results: The sample was primarily female (82%) and non-Hispanic white (89%), with mean age of 53.9 years. Fatigue and patient-reported sleep disturbance were elevated in both groups at baseline and follow-up. Actigraphy revealed that the total sleep time was almost eight hours, and sleep percent was greater than 85% for both groups at both time points (normal range). Physical functioning was diminished and at the same level as a sample with serious illness. Mental functioning was in normal range. A repeated-measures analysis of variance revealed no statistically significant group-by-time effects for fatigue, sleep disturbance, or functional status. Unemployed individuals showed greater benefit from the EASE intervention, reporting less pain and symptom interference. Conclusion: Potential explanations include high variability and/or floor effect for fatigue, incorrect timing of measures, insufficient amount or dose of the intervention, and confounding effects of gender. Future research should consider screening for symptom severity and tailoring interventions.

KW - Cancer-related fatigue

KW - actigraphy

KW - psychoeducational intervention

KW - randomized controlled trial

KW - sleep disturbance

KW - symptom cluster

KW - telephone counseling

UR - http://www.scopus.com/inward/record.url?scp=77955573853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955573853&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2009.12.020

DO - 10.1016/j.jpainsymman.2009.12.020

M3 - Article

C2 - 20705231

AN - SCOPUS:77955573853

VL - 40

SP - 200

EP - 216

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 2

ER -